FairScope Lab
EN 繁中 简中

BIIB

Valuation Healthcare · Drug Manufacturers - General Data as of 2026-03-31

P/E Ratio · Metrics

P/E Ratio

21.29

PEG Ratio

0.45

Dividend Yield

-

Gross Margin

73.32%

Net Margin

12.89%

Revenue CAGR 3Y

0.20%

ROE

6.85%

ROA

4.33%

Buyback Yield

-1.16%

Current Ratio

3.06

Magic Earn Yield

5.49%

Altman Z-Score

2.88

Fair Value River

Score

Valuation 60
Profitability 33
Growth 1
Health 79
Yield 0
← Back to Dashboard